Guidance and Position Statements

This guidance statement addresses the potential adverse health effects associated with exposure to nanomaterials.

Arsenic exposure in humans can occur from multiple routes including diet. This guidance statement addresses arsenic exposure sources and pathways, adverse health effects of arsenic exposure and those subpopulations at increased risk, and the evaluation and treatment of those exposed to elevated arsenic levels.

This guidance statement clarifies current best practices in the diagnosis of occupational noise-induced hearing loss.

This guidance statement discusses the role of occupational medicine clinicians in the supervision of audiometric surveillance under the auspices of hearing conservation programs.

This position statement recommends a set of specific questions to measure patient satisfaction in OEM, designed to meet anticipated regulatory requirements, facilitate quality improvement of participating OEM practices, facilitate casemanagement review, and offer fair and accurate assessment of OEM physicians.

This 2-part guidance statement explores the strength and importance of the corporate medical director.

This guidance statement recommends best practices for determining an industrial firefighter’s fitness-for-duty, and where possible, characterizes the demographic make-up of the industrial firefighter.

This guidance statement focuses on North American workers' health effects that may occur as a result of climate change and describes the responsibilities of the OEM provider in responding to these health challenges.

Utilization review (UR) is an element of workers' compensation (WC) systems in some jurisdictions and under consideration in others. This position statement provides a high-level overview of UR as it releates to WC.